Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1983-10-8
pubmed:abstractText
Immune complexes (IC) present in sera from patients with Hodgkin's disease (HD) were isolated using three different affinity columns: C1q-degalan, anti-C1q sepharose and conglutinin (K)-degalan. The isolated IC were analysed by immunoprecipitation, SDS-PAGE and sucrose density gradients and compared with IC similarly isolated from patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and in vitro prepared BSA-anti-BSA complexes. Isolated material from each disease, and BSA-anti-BSA complexes contained proteins compatible with true immune complexes--IgM, IgG, C1q and C3 breakdown components. Albumin, fibronectin and CRP, whose affinity for IgM, C1q and C3 are known, were co-isolated along with IC material. The size of isolated IC in HD ranged from 8-40S on sucrose density gradients. Despite the operational difference in detecting and isolating HD complexes via the C1q ligand (C1q-degalan or anti-C1q column) and C3bi (K-degalan), material purified by both methods showed remarkable similarity on SDS-PAGE and immunoprecipitation analysis. Although IC isolated from different diseases showed disparate banding patterns on SDS-PAGE this was attributed to a variation in the relative concentrations of constituent proteins--IgM, IgG and C3 breakdown products. IgM, IgG and C3 bind loosely, and non-specifically, to macromolecular aggregates formed around immune complexes. Using the anti-C1q column, most of this material could be eluted using 0.02M EDTA. Least protein, yet the most specific for antigen and antibody was eluted at pH 3.0.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/6411401-1245740, http://linkedlifedata.com/resource/pubmed/commentcorrection/6411401-13578996, http://linkedlifedata.com/resource/pubmed/commentcorrection/6411401-14302464, http://linkedlifedata.com/resource/pubmed/commentcorrection/6411401-332422, http://linkedlifedata.com/resource/pubmed/commentcorrection/6411401-4139208, http://linkedlifedata.com/resource/pubmed/commentcorrection/6411401-4169036, http://linkedlifedata.com/resource/pubmed/commentcorrection/6411401-498587, http://linkedlifedata.com/resource/pubmed/commentcorrection/6411401-5432063, http://linkedlifedata.com/resource/pubmed/commentcorrection/6411401-55719, http://linkedlifedata.com/resource/pubmed/commentcorrection/6411401-6168704, http://linkedlifedata.com/resource/pubmed/commentcorrection/6411401-648026, http://linkedlifedata.com/resource/pubmed/commentcorrection/6411401-6811171, http://linkedlifedata.com/resource/pubmed/commentcorrection/6411401-6974103, http://linkedlifedata.com/resource/pubmed/commentcorrection/6411401-6993918, http://linkedlifedata.com/resource/pubmed/commentcorrection/6411401-712061, http://linkedlifedata.com/resource/pubmed/commentcorrection/6411401-7204988, http://linkedlifedata.com/resource/pubmed/commentcorrection/6411401-7387837, http://linkedlifedata.com/resource/pubmed/commentcorrection/6411401-850071
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0009-9104
pubmed:author
pubmed:issnType
Print
pubmed:volume
53
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
308-18
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1983
pubmed:articleTitle
Immune complexes in Hodgkin's disease: isolation, immunochemical and physico-chemical analysis.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't